Keyword: Harvoni

News

High Drug Prices Said Pressuring US Medicare

26.07.2016 - Drugmakers who supply Medicare, the US health insurance for the elderly, are raking in billions of dollars for “pricey medications” at taxpayer expense, a report by the news agency...

News

Merck Wins Hepatitis C Patent Row with Gilead

24.03.2016 - A federal jury in California has ruled in favour of US drug maker Merck in a high-profile patent dispute with rival Gilead Sciences over sofosbuvir, the active ingredient in a new...

News

Express Scripts to List Dariprim Alternative for $1

02.12.2015 - Express Scripts Holding, the biggest pharmacy benefits manager in the US, said it plans to list Imprimis Pharmaceuticals’ cheaper alternative to the toxoplasmosis treatment...

News

European Price Wars Seen Shaping up Over Hepatitis C Drugs

20.01.2015 - Europe, where about 15 million people are believed to be infected with hepatitis C, could become the next battleground between US drugmakers Gilead Sciences and AbbVie in their...

News

US Insurer Aetna to Reimburse Gilead Hepatitis Drug

19.01.2015 - The largest US health insurer, Aetna, has negotiated a discount for Gilead Sciences' hepatitis C treatment regime and said it plans to offer this as a preferred choice for its...

News

Express Scripts to Reimburse AbbVie Hepatitis C Drug

23.12.2014 - The largest pharmacy benefit manager in the US, Express Scripts, has negotiated a cheaper price from AbbVie for its Viekira Pak hepatitis C treatment approved by the US Food and...